Skip to main content
. 2016 Oct;11(10):1793–1797. doi: 10.1016/j.jtho.2016.06.017

Figure 1.

Figure 1

Survival in patients after curative-intent surgical resection of NSCLC. (A) Disease-free survival (DFS) and (B) 3-year overall survival (OS) according to pulmonary vein circulating tumor cell (CTC) status. (C) DFS and (D) 3-year OS according to peripheral vein CTC detection. (E) DFS and (F) 3-year OS stratified according to high- and low-risk CTC groups. CMT, circulating tumor microemboli.